Back to results
US 2016/0101047 A1Published application
Adult and neonatal stem cell therapy to treat diabetes through the repair of the gastrointestinal tract
AssigneeEndoCellutions, Inc.
InventorsNeil F. Duffy, JR., Andrew McGillicuddy
Life of this patent
Estimating the term…
Abstract
The anatomic and functional arrangement of the gastrointestinal tract suggests an important function of this organ is its ability to regulate the trafficking of metabolites as well as control the equilibrium between tolerance and immunity through gut-associated lymphoid tissue, the neuroendocrine network, and the intestinal epithelial barrier. Combining nucleated cells from various tissues and introducing them directly into the small intestine will have a positive effect on diabetes.
Claims14
-10. (canceled)
A method to treat diabetes comprising:
- implanting nucleated cells including stem cells from multiple source tissues directly into tissue of the duodenum to reset or repair the immune system or to reset or repair metabolite production in the duodenum, the nucleated cells being a heterogeneous population of cells and including cells from a bone marrow aspirate, a fat aspirate, cord blood, Wharton's Jelly, or afterbirth tissue.
Dependencies are inferred from the claim text.